FR2797441B1 - Derives des cyclohexane, cyclohexene, cyclohexadiene et benzene pour la preparation de ligands du recepteur du mannose - Google Patents

Derives des cyclohexane, cyclohexene, cyclohexadiene et benzene pour la preparation de ligands du recepteur du mannose

Info

Publication number
FR2797441B1
FR2797441B1 FR9909928A FR9909928A FR2797441B1 FR 2797441 B1 FR2797441 B1 FR 2797441B1 FR 9909928 A FR9909928 A FR 9909928A FR 9909928 A FR9909928 A FR 9909928A FR 2797441 B1 FR2797441 B1 FR 2797441B1
Authority
FR
France
Prior art keywords
cyclohexadiene
cyclohexene
cyclohexane
benzene
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9909928A
Other languages
English (en)
Other versions
FR2797441A1 (fr
Inventor
Cyrille Grandjean
Oleg Melnyk
Masse Helene Gras
Gerhild Angyalosi
Corinne Rommens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR9909928A priority Critical patent/FR2797441B1/fr
Priority to AU68469/00A priority patent/AU6846900A/en
Priority to PCT/FR2000/002194 priority patent/WO2001009173A2/fr
Priority to JP2001513979A priority patent/JP2003506335A/ja
Priority to CA002388663A priority patent/CA2388663A1/fr
Priority to EP00956573A priority patent/EP1200462A2/fr
Publication of FR2797441A1 publication Critical patent/FR2797441A1/fr
Application granted granted Critical
Publication of FR2797441B1 publication Critical patent/FR2797441B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02Linear peptides containing at least one abnormal peptide link

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR9909928A 1999-07-30 1999-07-30 Derives des cyclohexane, cyclohexene, cyclohexadiene et benzene pour la preparation de ligands du recepteur du mannose Expired - Fee Related FR2797441B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR9909928A FR2797441B1 (fr) 1999-07-30 1999-07-30 Derives des cyclohexane, cyclohexene, cyclohexadiene et benzene pour la preparation de ligands du recepteur du mannose
AU68469/00A AU6846900A (en) 1999-07-30 2000-07-28 Use of quinic, shikimic acids and their derivatives for preparing mannose receptor ligands
PCT/FR2000/002194 WO2001009173A2 (fr) 1999-07-30 2000-07-28 Utilisation des acides quinique, shikimique et de leurs derives pour la preparation de ligands du recepteur du mannose
JP2001513979A JP2003506335A (ja) 1999-07-30 2000-07-28 マンノースレセプターリガンドを調製するためのキナ酸、シキミ酸およびそれらの誘導体の使用
CA002388663A CA2388663A1 (fr) 1999-07-30 2000-07-28 Utilisation des acides quinique, shikimique et de leurs derives pour la preparation de ligands du recepteur du mannose
EP00956573A EP1200462A2 (fr) 1999-07-30 2000-07-28 Utilisation des acides quinique, shikimique et de leurs derives pour la preparation de ligands du recepteur du mannose

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9909928A FR2797441B1 (fr) 1999-07-30 1999-07-30 Derives des cyclohexane, cyclohexene, cyclohexadiene et benzene pour la preparation de ligands du recepteur du mannose

Publications (2)

Publication Number Publication Date
FR2797441A1 FR2797441A1 (fr) 2001-02-16
FR2797441B1 true FR2797441B1 (fr) 2001-10-12

Family

ID=9548718

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9909928A Expired - Fee Related FR2797441B1 (fr) 1999-07-30 1999-07-30 Derives des cyclohexane, cyclohexene, cyclohexadiene et benzene pour la preparation de ligands du recepteur du mannose

Country Status (6)

Country Link
EP (1) EP1200462A2 (fr)
JP (1) JP2003506335A (fr)
AU (1) AU6846900A (fr)
CA (1) CA2388663A1 (fr)
FR (1) FR2797441B1 (fr)
WO (1) WO2001009173A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101245068A (zh) 2007-02-14 2008-08-20 浙江医药股份有限公司新昌制药厂 结晶型态的恩替卡韦及其制备方法和其药物组合物及用途
CN101284799B (zh) * 2007-03-23 2013-04-03 浙江医药股份有限公司新昌制药厂 咖啡酰奎宁酸含氮衍生物及其制备方法和其药物组合物及用途
CN101397333A (zh) 2007-09-27 2009-04-01 浙江医药股份有限公司新昌制药厂 去羟基万古霉素及其制备方法、和其药物组合物及其用途
CN101828693B (zh) 2009-03-09 2013-01-02 浙江医药股份有限公司新昌制药厂 制备低粘度高流动性类胡萝卜素油悬浮液的方法及其应用
KR102016961B1 (ko) * 2011-02-09 2019-09-02 노보자임스 에이/에스 피부질환 치료용 펩티드

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5432260A (en) * 1991-05-03 1995-07-11 Washington University High affinity mannose receptor ligands
EP0738154A1 (fr) * 1993-08-06 1996-10-23 Abbott Laboratories Analogues de lhrh a extremite n-terminale modifiee

Also Published As

Publication number Publication date
JP2003506335A (ja) 2003-02-18
WO2001009173A3 (fr) 2001-08-16
FR2797441A1 (fr) 2001-02-16
WO2001009173A2 (fr) 2001-02-08
EP1200462A2 (fr) 2002-05-02
AU6846900A (en) 2001-02-19
CA2388663A1 (fr) 2001-02-08

Similar Documents

Publication Publication Date Title
DK1140828T3 (da) 3-Azabicyclo[3.1.0]hexan-derivater som opiat-receptorligander
ATE266655T1 (de) Dibenzopyrane als glucocorticoid-rezeptor- antagonisten für die behandlung von zuckerkrankheit
MA26621A1 (fr) Composition pour aerosols pharmaceutiques
MA25433A1 (fr) Derives d'arylmethyl-carbonylamino-thiazole, leur procede de preparation et leur utilisation en tant qu'agents antitumoraux
FR2758723B1 (fr) Utilisation des antagonistes des recepteurs aux cannabinoides centraux pour la preparation de medicaments
DE69617371D1 (de) Ionische Verbindungen und Katalysator für die Olefinpolymerisation, der die Verbindungen verwendet
NO20014957L (no) Fremgangsmåte for fremstilling av aminplatinakomplekser
MA25403A1 (fr) Ligandes de recepteur de melanocortine
HUP0401924A3 (en) Cannabinoid receptor ligands, their use and pharmaceutical compositions containing them
HUP0304060A3 (en) Cannabinoid receptor ligands, their use and pharmaceutical compositions containing them
FR2799124B1 (fr) Utilisation des antagonistes des recepteurs aux cannabinoides centraux pour la preparation de medicaments
NO976084D0 (no) Ny, stabil legemiddeltilberedning for dannelse av drivgassfrie aerosoler
DE69841653D1 (de) Katalytische monoklonale antikörper mit proteaseaktivität zur selektiven lysis der proteinkomponente von mit pathologischen konditionen zusammenhängenden plaques und aggregaten
ATE304530T1 (de) Substituierte 1,5-dihydropyrrol-2-on-derivate wirksam als nmda-rezeptor-antagonisten für die behandlung von schmerzzuständen
MA26933A1 (fr) Derives de 4-phenyl-pyridine en tant qu'antagonistes de recepteur de la neurokinine 1.
DE60032905D1 (de) Selektive iglur5 rezeptorantagonisten zur behandlung der migräne
FR2801553B1 (fr) Agencement pour la protection des passagers sur des sieges de telesiege
ATE422498T1 (de) Tetrahydro-pyrazinoä1,2-aüindole für die behandlung von krankheiten des zentralnervensystems
FR2788696B1 (fr) Utilisation de derives de pyridazino [4,5-b] indole-1-acetamide pour la preparation de medicaments destines aux maladies du systeme nerveux central
IT1319240B1 (it) Procedimento per la oligomerizzazione selettiva dell'etilene.
FR2797441B1 (fr) Derives des cyclohexane, cyclohexene, cyclohexadiene et benzene pour la preparation de ligands du recepteur du mannose
IT1276155B1 (it) Catalizzatori per l'ossiclorurazione dell'etilene,procedimento per la loro preparazione e procedimento di ossiclorurazione impiegante gli
FR2727877B1 (fr) Catalyseur pour l'hydrogenation selective simultanee de diolefines et de nitriles, et procede de preparation de celui-ci
DE69736406D1 (de) Feste arzneizubereitung für die mundhygiene
NO973610D0 (no) Nytt farmasöytisk preparat

Legal Events

Date Code Title Description
ST Notification of lapse